On December 23, 2024, Binance announced the launch of the 63rd project on Binance Launchpool - Bio Protocol (BIO), a governance and liquidity protocol for decentralized science (DeSci).
Users can invest BNB and FDUSD into the BIO reward pool on the Launchpool website after 08:00 (UTC+8) on December 24, 2024, to earn BIO. The BIO activity lasts for a total of 10 days.
New Coin Listing
Binance will list Bio Protocol (BIO) on January 3, 2025, at 18:00 (UTC+8), and open trading markets for BIO/USDT, BIO/BNB, BIO/FDUSD, and BIO/TRY, applicable to seed tag trading rules.
1. Launchpool Details
Token Name: Bio Protocol (BIO)
Total Genesis Token Supply: 3,320,000,000 BIO
Maximum Token Supply: 3,320,000,000 BIO (supply can be increased through network governance)
Initial circulating supply at Binance's listing: 1,296,529,168 BIO (39.05% of the total genesis token supply)
Total Launchpool: 99,600,000 BIO (3% of the total genesis token supply)
Token contract and network details: Ethereum, 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
Restrictions: KYC required
Individual hourly reward hard cap
BNB Mining Pool: 35,275 BIO
FDUSD Mining Pool: 6,225 BIO
Reward Pool:
BNB Pool: Total reward 84,660,000 BIO (85%)
FDUSD Pool: Total reward 14,940,000 BIO (15%)
Event Time: UTC+8 from 08:00 on December 24, 2024, to 08:00 on January 3, 2025
2. Introduction to Bio Protocol (BIO)
BIO is a governance and liquidity protocol for decentralized science (DeSci). Its mission is to enable a global community of patients, scientists, and biotechnology professionals to co-fund, build, and own tokenized biotechnology projects and intellectual property (IP), thereby accelerating the development of biotechnology.
The team behind BIO helped create Molecule (a tokenized platform for early biomedical research) and VitaDAO (the largest decentralized community for longevity science). Based on these successes, BIO aims to catalyze an on-chain scientific economy through decentralized funding, incentives, and liquidity.
The protocol aims to catalyze the on-chain economy of the scientific community (bioDAO) and create a deep, liquid, and efficient market for scientific IP developed by bioDAO.
Core advantages of BioDAO compared to traditional scientific models:
Capital Efficiency: Concentrating resources to reduce innovation costs
Flexible work model: Allowing part-time experts to contribute
Shared Intellectual Property: Incentivizing contributions through intellectual property
Open Access: Removing barriers to scientific funding and decision-making
Diversified Portfolio: Bundling multiple biotechnology projects to reduce risk
3. Token Economics
BIO Tokens
BIO is the native governance token of the BIO protocol. Holders can use BIO tokens:
• Supporting specific bioDAOs (project screening and management);
• Voting on future issuance or allocation of BIO tokens;
• Implementing accelerator programs to promote network development.
BIO tokens provide the following rights to holders:
• Governance rights within the bioDAO network;
• Participating in early bioDAO funding rounds;
• Economic rewards for contributing health data and participating in clinical trials;
• Priority access to bioDAO funding for new health products.
BIO tokens are issued by the Bio.xyz Association, a non-profit organization responsible for the legal custodianship of BIO infrastructure and treasury.
• BIO token contract address: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
• vBIO (locked BIO) token contract address: 0x0d2ADB4Af57cdac02d553e7601456739857D2eF4
Initial Distribution
Total Supply: 3,320,000,000
BIO token status: Non-transferable
Maximum Supply: Unlimited supply, to be decided by votes from the BIO governance body.
New BIO can be minted for future protocol or network growth. This requires deploying a new token contract to replace the current BIO tokens.
On token distribution, community (total 56%):
- Community Airdrop (6%): 199,200,000 BIO
- Community Auction (20%): 664,000,000 BIO
- Ecosystem Incentives (25%): 830,000,000 BIO
- Molecule Ecosystem Fund (5%): 166,000,000 BIO
Other allocations are as follows:
- Core Contributors (21.2%): 703,840,000 BIO
- Investors (13.6%): 451,520,000 BIO
- Molecule (5%): 166,000,000 BIO
- Advisors (4.2%): 139,440,000 BIO
$BIO token holders vote to fund specific scientific IP assets, rewarding BioDAO for minting IP tokens, or funding community and infrastructure programs for DeSci DAOs. By monetizing IP (intellectual property), revenue can be generated from IP licensing, IP-NFTs, and data contributions. The revenue is reinvested into BioDAO to fund more and better scientific projects, thereby driving the value of $BIO tokens and empowering their value.